Recombinant adenovirus synthesizing cell surface-anchored beta hCG induces bioneutralizing antibodies in rats.
A recombinant adenovirus (re-Ad) has been constructed that synthesizes a cell surface-anchored form of the beta-subunit of human chorionic gonadotropin (beta hCG). This was achieved by in-frame fusion of beta hCG cDNA at its C terminus with the gene sequences coding for the vesicular stomatitis virus glycoprotein (VSVg) transmembrane domain. The fusion protein gene was placed under the control of human cytomegalovirus (hCMV) immediate early promoter and this expression cassette was inserted into the E1 region of Ad type 5 by homologous recombination. In vitro experiments using re-Ad-infected 293 cells showed that beta hCG fusion protein was made as early as 6 h post infection and the protein was anchored to the cell membrane as seen by immunofluorescence staining. The re-Ad induced bioneutralizing antibodies (Ab) to hCG when inoculated in rats through intraperitoneal or intramuscular routes. The Ab were made in a dose-dependent manner. However, orally delivered re-Ad failed to generate any significant immune response.
Raikwar
S P
SP
National Institute of Immunology, New Delhi, India.
Malik
P
P
Singh
O
O
Vrati
S
S
D000256:Adenoviridae / Q000235:genetics*; D000818:Animals; D000917:Antibody Formation / Q000235:genetics*; D018997:Chorionic Gonadotropin, beta Subunit, Human / Q000096:biosynthesis*; D018076:DNA, Complementary; D006801:Humans; D009500:Neutralization Tests; D010957:Plasmids; D051381:Rats; D017208:Rats, Wistar; D011995:Recombination, Genetic; D014614:Vaccines, Synthetic / Q000235:genetics / Q000276:immunology
D018997:Chorionic Gonadotropin, beta Subunit, Human; D018076:DNA, Complementary; D014614:Vaccines, Synthetic